A phase I tolerance and safety study of Sailuotong capsule

Chinese Journal of New Drugs

Volumn 21, Issue 1, 2012, Pages 62-67

  Li, Tao ^a   Liu, Hong Mei ^a   Lu, Yan ^a   Jia, Zeng Qin ^a   Xu, Li ^a   Gao, Rui ^a   Liu, Jun Feng ^b   Liu, Jian Xun ^a   Tang, Xu Dong ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b Shineway Pharmaceutical Co Ltd   (China)

Author keywords

Phase Iclinical trail; Safety; Sailuotong capsule; Tolerance

Indexed keywords

PLACEBO; PLANT MEDICINAL PRODUCT; SAILUOTONG; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG CAPSULE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; HEARTBURN; HUMAN; LOW DRUG DOSE; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SKIN PAIN; URTICARIA;

EID: 84863360517     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. 2002.
2. 2009: 135-138.
3. 2008, 33(5): 531-534.
4. 2008, 29(3): 353-355.
5. 1996, 4: 34-35.
6. 2004, 13(7): 956-957.
7. 1999, 10(4): 311.
8. 2007, 16(22): 59-61.
9. 2009, 3(1): 33-34.
10. 2005, 5(9): 1774-1775.